Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02395900

The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

The Effects of Flaxseed Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Sponsor: National Nutrition and Food Technology Institute

Conditions Non Alcoholic Steatohepatitis

Interventions Flaxseed control

Updated 5 times since 2017 Last updated: Mar 21, 2016 Started: Mar 31, 2014 Primary completion: Aug 31, 2014 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Non Alcoholic Steatohepatitis, this trial is completed. The trial is conducted by National Nutrition and Food Technology Institute and has accumulated 5 data snapshots since 2014. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Nutrition and Food Technology Institute

Data source: National Nutrition and Food Technology Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.